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Primary diastolic dysfunction rfailure is a distinct pathophys- 
iologic entity. It results from increased resistance to ventricular 
tilling, which leads to an inappropriate upward shift of the 
diastolic pressure-volume relation, particularly during exercise 
(exercise intolerance), The cawes of diastolic failure are inappro- 
priate tachycsrdia, decreased diastolic compliance and impaired 
systolic relaxation. Impaired (incomplete or slowed) systolic re- 
laxation must be conceptually distimgu~he~ from com~asatory 
Diastolic failure of the heart is a widely recognized clinical 
entity. Whereas most cases of diastolic failure are secondary 
to systolic failure and are part of the terminal picture of 
congestive heart failure, there also exists a primary form of 
diastolic failure commonly defined as “a condition with 
classic findings of congestive failure with abnormal diastolic 
but normal systolic function at rest” (l-9). Because the first 
symptoms ofcongestive diastolic failirre oft*:n occur during 
exercise, xercise intolerance is considered asan early sign 
of diastolic failure (10). It is observed as an early event in 
many clinical conditions, uch as hypertrophic cardiomyop- 
athy (including aortic stenosis and hypertensiilz heart dis- 
ease) and ischemic cardiomyopathy. In this sense, diastolic 
dysfunction with manifest diastolic failure during exercise 
is more common than originally thought (that is, approxi- 
mately 40% of all conditions of congestive heart failure 
seem to evolve from diastolic failure). Nevertheless, isolated 
left ventricular diastolic failure or dysfunction has been 
shown to be associated with a low cardiac mortality rate; at 
the same time, it is associated with substantial morbidity 
(11). 
Because there is often confusion about he use of the 
terms dimtole and diastolic firnction or dysfunction, one 
should first make clear what component or phase of the 
cardiac ycle is under consideration. We therefore first 
consider the t rm dhtole and reexamine the definition of 
diastolic failure. We then review some of the known causes 
and discuss ome therapeutic implications. 
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prolonged systolic ~~tra~t~~~ i&z1 
Optimal therapy will d 
drugs. 
The heart is a muscular pump. In the same way as in 
isolated cardiac muscle, adecrease irh force and relengthen- 
ing during relaxation of an afterloaded twitch are parts of one 
activity transient ( hat is, part of one contraction-~e~axat~o~ 
cycle [or “systole”]), a decrease inventricular p essure and 
an increase in ventricular volume during early rapid filling 
are closely related to this activity transient and should 
therefore be considered as part of sirstole (12). On these 
conceptual grounds, the term dinstole should be restricted to
the phase during the cardiac ycle that separates two such 
consecutive contraction-relaxation transients, that is, to the 
diastasis and the atria1 contraction phase, or approximately 
the last 5% to 15% of volume change during cardiac filling on 
a pressure-volume diagram (Fig. I, points 3 to 4). 
The previous definition of diastolic failure should there- 
fore be restated as follows: “a condition resulting from an 
increased resistance to filling of one or both ventricles, 
leading to symptoms of congestion due to an inappropriate 
upward shift of the diastolic pressure-volume relation (that 
is, during the terminal phase of the cardiac ycle). Whether 
this upward shift of the diastolic pressure-volume relation is 
caused by increased pressure for a given vcalume or by 
increased pressure inappropriate or disproportionate to the 
increase in volume or whether the shift is symmetric or 
asymmetric will not affect he henaodynamic consequences: 
pulmonary wedge pressure will increase (10). Accordingly, 
the upward shift of the diastolic pnss:u-e-volume relation 
may lead to symptoms of congestion, often at rest but 
particularly during exercise, manifesting asexercise intoler- 
ance. This shift may ajso lead to subendocardial ischemia 
and, if chronic, to remodeling and hypertrophy of the 
ventricle. 
A common problem in science is the difficula~~ in formu- 
lating the appropriate questions. In the publisher; reports on 
DECREASEO 
q lASlOLlC 
‘COMPLIANCE 
d_xlivision of the cardiac cycle into systole IS) 
illustrating the causes of diastolic faib-e: CONT 
, IC .- iso~oiiimerric oaPracPion: IR = 
isovolumetric elaxation; = pressure; = rapid filling phase; 
V = volume. 1 = aortic valve closure; 2 = mitml vdvk opening; 3 = 
end of early rapid filling; 4 = e~d-d~ast~~~. Modified from Brutsaert 
and Sys (12). 
ary diastolic failure, two basic questions have been 
efore cohltraction I!? many in- 
ventricular elaxation, inc 
dominantty caused by ab 
may be di2gncsed by so-ca late relaxation measure- 
ments, such as a prolongation of tau or a decreased rapid 
filling rate. If, however, only the ve;-j early time course of 
relaxati@cl is impaired (for example, because of impaired 
contractile pro ~nter2ctio~ and detachment), meas 
ments that into ate this early phase of relaxation, sue 
stroke aork, ejection fr2ction, end-systolic pressure-volglme 
relation. ;eak neg2Gve first derivative of Ieft rc I# alar 
pressure (dP/dt) may be abnormai even in the presence of 
norm21 Bate rei2xtitios indexes. In most clinical conditions, 
however, contraction 2nd relaxation abnorm2!ities are 
A 
IMAPPROPRlAW 
TACHVCARDIA 
e causes are 
ab~~rm2l~ties of t
result in decreased 
all three act in concert. 
ure, the eliciting patbo- 
,part from direct compression 
~e~cardia~ pressure, which will be transmitted to the left 
ventricle, wherf. it will ftirther increase the diastolic 
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Table 1. Various Conditions of Decreased Diastolic Compliance 
as Causes ofDiastolic Failure 
Structural and geometric changes of the ventricular wall 
Restrictive csrdiomyopathg (interstitial fibrosis. edematous infiltration, 
collagen remodeling, amylddosis, hemosiderosis) 
Primary and secondary hypertrophic cardio~lyopathy, asymmetric septal 
hypertrophy 
Postmyocardial infarction scarring, aneurysm 
Endo~%yGZXdia! Co&, i%ii&iSi~SiS 
Ischemia (rigor bridges?) 
Extraventdcular causes 
____;_:_; _I Rikiiiizii ~.VIIJLLOIIII @WiCalliiai eu”usion, constriction, venrricuiar 
enlargement) 
Right-left ventricular cross-talk 
Pulmonary diseases 
pressure-volume relation, with no direct repercussion  
systolic function (17). Equally important and often related to 
conditions ofpericardial constraint is the potential functional 
importance of right-!eft ventricak interdependence i  tori- 
ditions of acute unilateral right ventricular overload. The 
resultlag “cross-talk” may have implications with respect to 
some more specific linical conditions or to some forms of 
treatment; for example, pulmonary embolism or drug inter- 
ventions that act on r.he loading conditions of the right 
ventricle may indirectI,* also affect measured left ventricular 
compliance during diaztole. 
A common cause of diastolic failure is impaired (or 
slowed or incomplete) systolic relaxation ofthe left ventri- 
cle. Impaired nlaxation must be distinguished from delayed 
or retarded relaxation. the latter condition should preferably 
be called prolonged contraction (Fig. 2). Although both 
conditions are often barely distinguishable in clinical cardi- 
ology, it is important to make the distinction on conceptual 
Figure 2. Impaired sysMic relaxation (right) cos.ipared with condi- 
tions of prolonged systolic contraction Oefi). Impaired systolic 
relaxation, but not prolonged contraction, can be a cause of diastolic 
failure. a, b, c = without (a) or with (b, c) physiologic changes in rate 
of relaxation; -dP/dt = peak negative first derivative of left ven- 
tricular pressure; 7 = time constant of isovolumetric relaxation: 
other abbreviations as in Figure I. 
e 
‘etayed 1 relaxation retarded _I 
slowed 
incomplete relaxalion 
grounds and for practical diEgnostic and therap 
erations. Whereas impaired systolic relaxatio 
pathophysiologic process that is always delete 
long run, prolonged contraction is ~~ysi~~~gi 
in itself deleterious. 
systok The primary event 
y prolong ion is a delayed onset 
relaxalisii, regardless of MWMIei ir iS accompaiiied bji pii_ 
iologic hanges ia the rate of relaxation. An upward shift of 
the pressure-v~~~rne elatiQ~ during true diastole is not 
observed in cQnditio~s of co 
tion; an exception totkis rule e seen at i~approp~iate~ 
high heart rates. The caus 
k frogs and k&r by Sta 
rtrophy, at least d~r~~~ t 
nary vascular (20-22) and e~docardial (22-27) 
(Fig. 3. right) induce similar changes in the 
systole. Substances such as angi~te~si~ II, ca 
(alpha,-agonist activity) a vasopressin, whose 
levels may all be increased 
tions of heart failure, elicit a similar esponse in systolic 
duration (25). As stated before, the mere prol~~gat~Q~ sf 
can be accompanied by moderate ( hat is, phys- 
nges in the rate of co traction or relaxation. 
Physiologic modulation i the rate of contraction or relax- 
ation will depend on sympathetic drive (28), plasma cate- 
cholamines (beta-adrenergic a onist activity) (29), instanta- 
neous changes in load during the cardiac ycle (30) and 
frequency potentiation induced by changes inheart rate (29), 
relaxation. By contrast, the primary 
event in impaired systolic relaxation is an inappropriately 
decreased rate or decreased extent of relaxation. As a 
consequence, relaxation exte ds into true diastole, with an 
upward shift of the pressure-volume relation. Ischemia and 
hypertrophy (at least iin the advanced phase of hypertrophy), 
as in aortic stenosis or hypertensive heart disease, are 
common causes of impaired relaxation. Nonuniformity of
ventricular performance, which often accompanies these 
two clinical conditions, may also constitute a cause of 
impaired reiaxation regardless of the degree and extent of 
underlying ischemia or hypertrophy (31). In all of these 
clinical conditions, an inappropriately decreased rate or 
exient of relaxation may indeed result from disturbances in 
the so-called triple control of relaxation; that is, 1) from 
impaired activation-inactivation (calcium homeostasis, sar- 
coplasmic reticulum pump, contractile proteins); 2) from 
excessive changes inload; or 3) from inappropriate nonuni- 
formities of load and activation-inaciiva,tion in time and 
cts of the three maj~ ulators of cardiac perfor- 
mance on systolic duration of press ime curves of canine left 
ventricle (22). For comparable changes in timing of relaxation, the 
rate-and pattern of relaxation were influenced d~ffe~e~t~y by the 
three types of modulation. Left ventricular presjurc (LVP) (top), 
first derivative of left ventricula PIdt ;‘?I. ;ine, nid91:) 
and phase-plane (d&‘/d? vs. LVP, *ings are displayed. Ir 
after 
dula- 
lume 
(heterometric autoregnlation or Frank Starling mechanism). Com- 
pared with baseline (big B, lowering left ventricular volume and 
pressure (k10w) indwced slightly lower rate bf pressure increase and 
early onset of decreaw in left v ricular pressure. As evident from 
the phase-plane tracing (hot panel), initial decrease in left 
ventricular pressure and peak negative dP/dt were slower at the 
lower end-diastolic volume, in contrast to the late decrease in left 
ventricular pressure, which was faster (i.e., projected below control 
space. An extensive discussion of the triple control of 
ing on a given disease and onthe instant during the devel- 
opment cf tha: disease, these two features can be present 
separately or in combination. This can be best illustrated by 
examining the ~atho~hysio~ogic evolution of pressure or 
volume overloading, orboth, of the left ventricle (as in Fig. 
4). Of importance is the general pattern trf the pathophysio- 
logic evolution with time and the pattern of the ~~divid~l 
pressure e~rves in each cardiac cycle. Zn the evolution of 
pressure and volume overloading with time, several phases 
can be distinguished. 7%: initial phase is compensatory, with 
typical prolonged corztraction a d, hence, delayed or re- 
duiatk of cardiac pa-for 
calcium chloride (0.05 mgkg body weight; 
of rise of pressure; left ventricular pressure 
h pm4s, ~odu~a~i~~ of cardiac perfmnance by e 
helium (eadotheli~m-mediated autoreg~lati0n) (20 
The endocardial endothelium was functionally inactivated by higd 
power. high frequency intracavitary ultrasound E- ). Compared 
baseline (+); peak ?eff ventricular pressure and peak positive 
remained unaltered. The decrease in left ventricular pressure was 
induced prematurely and revealed a slightly accelerated cciurse, 
evidenced by a slight increase in peak negative dP/ 
c in left ve~t~co~ar pressure on
wel) slightly belo;w the baseline 
; this may result fro 
tarling mecha~ism~, myocaudral h 
plasma levels of various component 
sin), among other factor5. In the 
inappropriately decreased rates of relaxation 
impairment of relaxation may disturb the clinical picture. 
Along with decreased compliance and increased rt rate, 
impaired relaxation may result in an upward s of the 
ress~re-volume relation g diastole (Fig. 2, rig 
resulting inexercise lntoler Hn the third phase of Figure 
4, conco~~ita~t systoolic failure develo s. Systolic failure 
results in ioss of systolic om~e~sat~o~ (that is, in decreased 
co~tract~~~ty during contraction and early 
e capacity to piOlOnU& systole; inst 
4, the onset of relaxation is often induced ~rerna~~r~~y 
further complicates the already existing clinical picture of 
diastolic failure. 
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systolic compensation 
with diastolic failure 
compensalory,prolonged contraction 
(delayedlrelarded relaxation) 
compensatory prolonged 
and I 
I 
impaired 
relaxation 
decreased 
6ompliance 
. ACE.lnhlbllw~ 
. dlwotko: load 1 
Figure 4. Successive phases during the pathophysiologic evolution 
of pressure or volume overloading, or both, of the left ventricle. 
Only pressure (P) vs. time curves are shown. The P curve in full is 
the baseline P curve before overloading. ACE = angiotensin- 
converting enzyme; ANF = atria1 natriuretic factor; CAMP = cyclic 
adenosine 5’-monophosphate; cGMP = cyclic guanosine S- 
monophosphate; NEP = neutral endopeptidase; PDE = phospho- 
diesterase; TnC = troponin C. In the data t bottom, 2 = increase 
and I = decrease. 
In patients with ischemic cardiomyopathy, these three 
phases may, at a myocardial evel and at any given time 
during the pathogenesis, develop simultaneously and inter- 
act with one another at the ventricular level. This may 
explain, at least in part, why diastolic dysfunction i differ- 
ent types of experimental a d clinical myocardial ischemia, 
such as coronary occlusion, rapid pacing in the presence ol” 
coronary stenosis, multivessel coronary heart disease, 
reperfusion and stunning, may be rather complex and not 
easily predictable. 
Accordingly, a!though it is clear from the latter two 
examples of hypertrophic and ischemic cardiomyopathy at 
the causes of diastolic dysfunction and failure are multifac- 
torial in most cardiac diseases (that is, based on a combina- 
tion of the three major causes described [Fig. I]), these 
pathophysiologic concepts hould be kept in mind when 
developing a diagnostic and therapeutic strategy. 
Implicatioas for the evaluation of relaxation. Figures 3 
and 4 illustrate that a full evaluation of systolic relaxation 
(that is, of isovolumetric pressure decline and early rapid 
filling), should encompass 1) measurements or indexes of 
i de of pressure decline and early rapid filling (peak negative 
urnetric relaxation t 
rate); 2) measurements of th 
rate) of the latter ate indexe 
patterns, including early, 
ltaneous measurem 
longed contraction and of impaired relaxation. The need to 
examine rate patterns during the entire course of relaxation 
has been emphasized by us before (12). This point is also 
obvious from phase-plane dP/dt versus pressure analysis 
(Fig. 3). where the rate of early pressure decrease, peak 
negative dP/dt and rate of late pressure decrease are re- 
vealed as three distinct aspects of relaxation. Inmost cases, 
peak negative dP/dt results from the transition from early to 
late rate of relaxation and may therefore not be representa- 
tive for the entire process of relaxation. Moreover, early and 
late relaxation rates may be affected ifferently and may 
oiren change in opposite directions (30). 
By extension, these measurements of systolic perfor- 
mance during relaxation should, in many clinical conditions 
or after various pharmacologic interventions (32), not nec- 
essarily be expected to correlate with measurements of 
diastolic function, such as diastolic pressure-volume rela- 
tions. 
r treating patients w 
to improve xercise tolerance by dimin 
upward shifts in the diastolic pressure-volume relation 
(Fig. 5). Although various drug regimens have been tested, 
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dependsupon 
/\ 
type phase 
of during 
cardiac diastolic 
disease failure 
:atl ion of drug therapy for the treatment of diastolic 
ina ropriate 
Pachycardia 
failure. Abbreviations as in Figures I and 4. 
no specific therapy is available. 
on the basis of the preceding classification of three cause5. 
ould similarly conceive three classes of potential drugs. 
hen inappropriate heart rate is the 
rugs are the treatment of 
g agents, calcium channel 
conditions (such as atriai 
fi.br:!!ation). digitalis IL.. _ .._ a\‘p 311 beer! sncressfti? in imprr?ving 
exercise tolerance due to primary diastolic failure. There 
have been several recent developments in such drugs. Some 
new molecules are potentially interesting with specific 
bradycarlic properties but, unlike the other drugs of this 
type, are devoid of direct inotropic actions on time m;‘ocar- 
dium (33). Ideally, these drugs should preferentially sup- 
press inappropriate increases in heart rate during exercise, 
with little or no effect on heart rate at rest. 
Little attention has been directed tow ’ the treatment of 
fundamental changes in myocardiai co 
the recent introduction of the concept 0 
particular in the prevention 3f cardi brosis and regression 
of hypertrophy, has emphasized potential use of so- 
called remodeling drugs (35,361. For example. various 
angiotensin-converting enzyme inhibitors and, more re- 
Treatment with bib-0 
ate a relation to reiaxairvn a 
ing in three successive 
ng on the relative contribu- 
tion of each one bases on ve~tr~c~~a~ perfor- 
mance at any given mo 
action on 
drugs. Diuretic drugs consistently improve exercise toier- 
ante with little change in systolic ~e~orma~ce~ probably 
directly through their effects on both right and left ventric- 
iastolic loading conditions as ;Nell as indirectly by 
reducing pericardial constraint on the left ventricle and on 
ventricular cross-talk (10,38). Calcium channel blockers 
‘hitropic is derived From the Greek words AM&i, meaning lOOSk 
releasing. ransoming, means of letting. deliverance from guilt. redemption of 
mortgage or pledge, emptying. evacuation, emission of semen. unraveling, 
softening or divorce, and ~pono(,ir. meaning turn, direction. way. manner or 
fashion. The tetm hitropic was coined by Phyllis B. Katz to mean predom- 
inantly acting (positively or negatively) on the relaxation of the keart both as 
muscle and as pump. The major advantage of the term /~siii’nPif. (that is. its 
potential usefulness as a general term to describe interventions that preferen- 
tially act on relaxation) unfortunately has the same limitations as the term 
hotropic for the contraction phase. In particular. it lacks SUffiCient SPeCifiCitY 
for the different phases to which the term is meant to relate during relaxation. 
Moreover. does it refer to changes in onset. in speed. in extent. or to changes 
jn the time pattern of relaxation with little changes in onset. in peak speed or 
extent. or a:\ ofthese? Does it refer tc kactivation. or does it also incotpot3te 
effects medi,,,ted through changes in loading? (11). 
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have been shown to improve xercise intolerance in phase? 
I and II shown in Figure 4 for still largely unknown reasons 
(including relief of ischemia, decrease in intracelhdar Cd- 
cium ioR overload and improvement of inappropriate non- 
uniformities [39-421) but are in our opinion expected to be 
deleterious in phase III. Nitrates, nitroprusside and related 
molecules have been shown to consistentiy decrease the 
diastolic pressure-volume relation (43,44) and therefore to 
improve xercise tolerance (10). A diminished diastolic load 
of both the ieft and the righ; ventricle and decreased peri- 
cardial constraint have been i voked to explain this benefi- 
cial effect. Equally important but largely overlooked inall 
previous studies, however, is the direct Sect cf nitrates+ 
nitroprusside and related molecules inabbreviating systolic 
duration, with no effect on contraction dynamics, by increas- 
ing myocardial intracellular cyclic guanosine Y-monophos- 
phate level (45). Such an effect could be particularly benefi- 
cial during phase II of the example shown in Figure 4. 
Similar to nitrates and nitroprusside. atrial natriuretic factor 
(45,46) and neutral endopeptidase inhibitors, which inhibit 
the breakdown of atria1 natriuretic factor, would at least 
theoretically also be xpected to be beneficiai in the treat- 
ment of diastolic failure. Partial beta-agonists may slightly 
shorten the duration of contraction, with little change in 
heart rate owing to the concomitant beta-blocking proper- 
ties. Such treatment could be advantageous in phase II, 
where it would suppress excessive systolic ompensatory 
prolongation while simultaneously accelerating the rate of 
relaxation. The latter drug actions would be deleterious, 
however, during monotherapy in the terminal phase of 
combined systolic and diasto!ic failure (47). For similar 
reasons, as well as for their vasodila,tor properties, phos- 
phodiesterase inhibitors may also decrease the diastolic 
pressure-volume relations, thus improving exercise toler- 
ance in patients with diastolic fnilure ‘during phase II, but 
should be given with caution in phase III. 
As explained b&ire, in many diseases (for example, 
ischemic ardiomyopathy and, more conclusively, when in 
combination with pressure-overload hypertrophy [13]), the 
somewhat rbitrary but conceptualiy useful subdivision i to 
the successive phases shown in Figure 4 is not always easily 
appreciated because various egments of the ventricular wall
may undergo successive phases at different moments and at 
different speeds. Here, the efficacy of a drug will depend on 
the relative contribution f any one ofthese phases present 
in the various segments of the ventricular wall at any 
moment during pathogenesis, 
Of interest, drugs with a positive or a negative Iusitropic 
action in a given clinical setting will, in other conditions, not 
necessarily act as positive or negative lusitropic “drugs.” 
VENOUS calcium-sensitizing drugs (48) as well as sodium 
channel openers (49), have often, but erroneously, been 
referred to as negative lusitropic because of their contrac- 
tion-prolonging effect. These cardiotonic drugs might indeed 
be less desirable inphase KI of the example shown in Figure 
4. During phase III, however, and in combination with 
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a~giote~si~-converting enzyme 
cium or sodium sensitization m 
and, hence, be positive lusitropic. 
agonists and calcium channel blockers might, 
stated, be useful in phase HI but not in phase 
words, there is no single standar 
treatment of diastolic failure. 
compensatory prolonged contraction (delay 
relaxation). Treatment of diastolic failure 
feasible but necessitates a clear understanding of the etiol- 
ogy, pathogenesis and pathophysiology of the ~~deriyi 
cardiac disease. Optimal therapy will depend on the type 
disease, on the phase during the pathophysiologic evolution 
of the disease and on the coexiste ative contribu- 
tion of various CQrn~e~sato~y or satory mecha- 
nisms. This often requires a comprehensive analysis of 
hemodynamics for example, with combined, echocardio- 
graphic and Doppler studies), completed, whenever neces- 
sary, by catheterization, both at rest and during exercise. 
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